-
Apollo Hospitals
6,900.70 5,690.80(%) -
Waaree Energies
2,590.20 1,808.65(%) -
Reliance Industr
1,288.00 1,115.55(%) -
SpiceJet
55.49 79.90(%) -
Axis Bank
1,145.75 934.00(%) -
Dixon Technolog.
16,092.55 7,935.00(%) -
Suzlon Energy
56.78 37.95(%) -
Vodafone Idea
7.44 6.60(%) -
SBI Life Insuran
1,763.00 1,935.00(%) -
Tata Motors
651.45 542.55(%) -
Bharat Electron
293.70 221.00(%) -
Tata Power Co.
382.00 326.25(%) -
Reliance Power
40.91 23.26(%) -
Eternal Ltd
226.95 146.85(%) -
HDFC Bank
1,891.90 1,430.15(%) -
Jio Financial
249.15 198.60(%) -
Mazagon Dock
2,585.00 1,046.00(%) -
Adani Energy Sol
907.00 588.25(%) -
Nip. India Nifty
266.61 242.12(%) -
Adani Green
904.00 758.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Supriya Lifescience Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Indian Private
- BSE Code : 75656.0
- ISIN : INE07RO01027
-
Today’s Low
675.05 -
Today’s High
712.80

-
Open
705.00 -
Perv Close
706.60 -
52W Low
330.00 -
52W High
842.00
Key Indicators
-
P/E(TTM)
31.76
-
Mar.Cap (₹Cr.)
5,542.05
-
Div & Yield %
0.12
-
Book Value(₹)
112.56
-
Debt-Equity Ratio
-2.55
-
AGM Date
25-Apr-2025
-
EPS
21.68
-
P/E Ratio
31.76
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
5,542.05
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
16.10
-
BV (₹)
112.60
-
Sales( ₹ in Cr.)
570.37
-
NP (in Cr.)
119.11
-
NP Var(%)
32.0
-
Div%
40.0
-
CPS (₹)
16.80
-
EPS (₹)
14.80
-
Traded Value (₹ in Lakhs)
5,688.93
-
52 Week High
842.00
-
52 Week Low
330.00
-
Price BSE
707.0
-
Price NSE
707.00
-
Market Capital( in Cr.)
5,688.93
-
P/C Ratio
42.20
-
P/E Ratio
47.80
-
Price Vs.BV
14.80
-
10-Mar-2025( 03:37)
Corporate News - Board... - The Board of Supriya Lifescien...
-
06-Mar-2025( 09:34)
Corporate News - Supri... - Supriya Lifesciences will hold...
-
24-Jan-2025( 05:00)
Results - Announcements - Supri... - Net profit of Supriya Lifescie...
-
17-Jan-2025( 11:05)
Corporate News - Supri... - Supriya Lifesciences will hold...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 646.96 | 516.47 | 588.52 | 430.97 | 311.64 | 321.28 |
Excise Duty | 76.59 | 55.53 | 58.47 | 39.76 | 0.00 | 43.44 |
Net Sales | 570.37 | 460.94 | 530.05 | 391.21 | 311.64 | 277.84 |
Other Income | 10.64 | 9.49 | 7.58 | 5.01 | 11.07 | 8.02 |
Stock Adjustments | -30.31 | 6.51 | 3.03 | 12.44 | 13.90 | -0.80 |
Total Income | 550.70 | 476.94 | 540.66 | 408.66 | 336.61 | 285.06 |
EXPENDITURE : | ||||||
Raw Materials | 191.43 | 187.32 | 198.83 | 140.57 | 152.38 | 146.07 |
Power and Fuel Cost | 21.37 | 20.95 | 14.07 | 9.24 | 8.97 | 0.00 |
Employee Cost | 67.64 | 55.58 | 49.08 | 32.76 | 18.88 | 0.00 |
Other Manufacturing Expenses | 34.38 | 28.87 | 18.44 | 13.15 | 8.27 | 0.00 |
Selling and Administration Expenses | 39.43 | 37.32 | 33.83 | 31.88 | 30.10 | 0.00 |
Miscellaneous Expenses | 9.80 | 8.51 | 4.84 | 2.92 | 8.56 | 0.00 |
Employee Benefit Expenses | 67.64 | 55.58 | 49.08 | 32.76 | 18.88 | 0.00 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 364.04 | 338.55 | 319.09 | 230.51 | 227.15 | 212.30 |
Operating Profit | 186.65 | 138.38 | 221.56 | 178.15 | 109.45 | 72.76 |
Interest | 5.15 | 3.08 | 4.20 | 4.08 | 6.85 | 10.22 |
Gross Profit | 181.50 | 135.30 | 217.36 | 174.07 | 102.60 | 62.54 |
Depreciation | 15.81 | 11.82 | 10.12 | 6.76 | 6.41 | 5.44 |
Profit Before Tax | 165.69 | 123.48 | 207.24 | 167.31 | 96.19 | 57.10 |
Current Tax | 37.10 | 30.68 | 52.19 | 43.02 | 25.07 | 17.00 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 9.48 | 2.95 | 3.25 | 0.69 | -2.23 | 0.68 |
Reported Net Profit | 119.11 | 89.86 | 151.81 | 123.59 | 73.35 | 39.42 |
Extraordinary Items | 0.00 | -0.08 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Net Profit | 119.11 | 89.94 | 151.81 | 123.59 | 73.35 | 39.42 |
Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | -3.36 | -0.29 |
P & L Balance brought forward | 486.16 | 401.13 | 253.72 | 134.08 | 79.08 | 40.02 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 4.83 | 4.83 | 4.39 | 3.96 | 14.64 | 0.00 |
P & L Balance carried down | 600.45 | 486.16 | 401.13 | 253.72 | 134.43 | 79.15 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 14.64 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 40.00 | 30.00 | 30.00 | 27.00 | 100.00 | 0.00 |
Dividend Per Share(Rs) | 0.80 | 0.60 | 0.60 | 0.54 | 10.00 | 0.00 |
Earnings Per Share-Unit Curr | 14.80 | 11.16 | 18.86 | 16.89 | 50.11 | 5.39 |
Earnings Per Share(Adj)-Unit Curr | 14.80 | 11.16 | 18.86 | - | - | - |
Book Value | 101.31 | 86.91 | 76.50 | 36.70 | 101.84 | 12.82 |
Book Value(Adj)-Unit Curr | 101.31 | 86.91 | 76.50 | - | - | - |